On November 17, 2011, the second protocol amendment to our ongoing observational study of ibogaine treatment for addiction was approved by the Human Research Review Committee (HRRC) at the California Institute …
On November 1, 2011, an independent Ethics Committee granted conditional approval for MAPS’ ibogaine research program in New Zealand, pending the submission of a few final documents. It was particularly …
On October 17, 2011, the lead investigators for MAPS’ ibogaine research program held a conference call to discuss the next steps for our new observational study of ibogaine treatment for addiction …
The 30th and final subject was enrolled in our ongoing observational study of ibogaine treatment for addiction on August 29, 2011. This final subject has completed treatment at an independent ibogaine …
MAPS has agreed to donate $15,000 to a new observational study of ibogaine treatment for addiction to take place in New Zealand, under the direction of Principal Investigator Geoff Noller, Ph.D., Research …
As of March 1, 2011, MAPS’ observational study of the long-term efficacy of ibogaine-assisted therapy for drug addiction has enrolled 16 out of 30 subjects. All participants in this study have already …
On December 17, 2010, MAPS Deputy Director Valerie Mojeiko released a request for proposals for clinical studies with ibogaine. While MAPS is currently sponsoring an ongoing observational study of ibogaine …
On Nov. 22, 2010, the fifth subject was enrolled in our observational study of ibogaine treatment for opiate addiction. On Dec. 2, the research team, led by Principal Investigator (and MAPS Deputy Director) …
From Oct. 13–16, MAPS Deputy Director Valerie Mojeiko will participate in an international ibogaine conference in Barcelona. She will speak about MAPS’ ibogaine outcome study. The workshop …
On Sept. 27, the first two subjects enrolled in our new ibogaine study at Pangaea Biomedics, a treatment facility in Playas de Tijuana, Mexico. It is led by Principal Investigator Valerie Mojeiko and co-investigator …
The first two subjects in our new ibogaine study were enrolled for treatment today.
New Ibogaine for Opiate Addiction Outcome Study Ready to Begin MAPS is embarking on a new study investigating long-term outcomes of ibogaine-assisted therapy for people with opiate addiction. Our previous …
